SciBase Holding Third Quarter 2024 Earnings Beats Expectations - Simply Wall St
| SCIB Stock | SEK 0.39 0.04 11.43% |
Slightly above 55% of Scibase AB's private investors are presently thinking to get in. The analysis of current outlook of investing in Scibase AB suggests that some traders are interested regarding Scibase AB's prospects. Scibase AB's investing sentiment can be driven by a variety of factors including economic data, Scibase AB's earnings reports, geopolitical events, and overall market trends.
Scibase |
SciBase Holding Third Quarter 2024 Earnings Beats Expectations Simply Wall St
Read at news.google.com
 |
Scibase AB Fundamental Analysis
We analyze Scibase AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scibase AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scibase AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Scibase AB is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Scibase AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scibase AB stock to make a market-neutral strategy. Peer analysis of Scibase AB could also be used in its relative valuation, which is a method of valuing Scibase AB by comparing valuation metrics with similar companies.
Peers
Scibase AB Related Equities
| EPIS-B | Episurf Medical | 7.14 | ||||
| XBRANE | Xbrane Biopharma | 5.56 | ||||
| SES | Scandinavian Enviro | 1.06 | ||||
| CANTA | Cantargia | 1.64 | ||||
| ACARIX | Acarix AS | 3.23 |
Additional Tools for Scibase Stock Analysis
When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.